Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
OPT 1 DO - ADMINISTRATIVE CORRECTION TO COVID 19 TESTING /MOLECULAR ANALYZER/REAGENTS - HIGH VOLUME OUTPUT ANALYZER WITHOUT THE NEED TO ALIQUOT - ADD PRODUCTS TO ATTACHMENT A is a federal award for 255-Network Contract Office 15 (36C255) held by Abbott Molecular Inc. Estimated value $1.6M ($1.6M obligated). Current period of performance ends Oct 14, 2022. Place of performance: DES PLAINES IL.
OPT 1 DO - ADMINISTRATIVE CORRECTION TO COVID 19 TESTING /MOLECULAR ANALYZER/REAGENTS - HIGH VOLUME OUTPUT ANALYZER WITHOUT THE NEED TO ALIQUOT - ADD PRODUCTS TO ATTACHMENT A
Recompete timing
PublicCurrent PoP ended Oct 14, 2022 (1407 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordAbbott Molecular Inc — $41.3M obligated across 47 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25522N0027?
36C25522N0027 (OPT 1 DO - administrative correction) is a 255-Network Contract Office 15 (36C255) award with a potential value of $1.6M, currently held by Abbott Molecular Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C255-22-N-0027?
36C255-22-N-0027 is the dashed form of PIID 36C25522N0027 (OPT 1 DO - administrative correction), held by Abbott Molecular Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25522N0027?
255-Network Contract Office 15 (36C255) awarded 36C25522N0027 to Abbott Molecular Inc (potential $1.6M).
Who is the incumbent on 36C25522N0027?
Abbott Molecular Inc is the incumbent with $41.3M across 47 related awards in SCOUT’s public footprint. The current period of performance ends Oct 14, 2022.
When does Abbott Molecular Inc’s 36C25522N0027 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 14, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.